AN

Allie Nawrat

Allie is an experienced business journalist; she has six years experience in the B2B tech media space. She has been highly commended by WTW as HR journalist of the Year for three years in a row and was an integral part of the Editorial team when UNLEASH won HR Publication of the Year in 2022.

Allie moderates UNLEASH webinars and roundtables, as well as external panels. She also has podcast & video experience, and to date has published over 1,000 pieces for UNLEASH.

    Covers

    Publications

    • pharmaceutical-technology.com
      247 articles
    • UNLEASH
      20 articles
    • Global Risk Regulator
    • Pharmaceutical Technology

    Writes Most On

    ChiefExecutiveOfficerCEOPharmaceuticalIndustryClinicalTrialPandemicCancerVirusVaccineHealthCareOncologyFDAFoodAndDrugAdministrationPipelineTransportCoronavirusDrugDevelopmentAntibodyInfectionEuropeanUnionMedicineGeneProteinResearchAndDevelopmentNeoplasmAstraZenecaBiotechnologyNovartisWorldHealthOrganizationEnzymeInhibitorPublicHealthChinaNationalHealthServiceChemotherapyPfizerPlaceboEuropeNHSClinicalEndpointImmuneSystemImmunotherapyDrugDiscoveryGeneticsBloodSARSCoronavirusAntigenReceptorListOfLifeSciencesTCellEUGeneTherapyArtificialIntelligence
    • Most Popular
    • Recent Work
    • Requests
    • —UNLEASH
    • —UNLEASH
    • Spotlight on BaseLaunch: fostering innovative start-ups in Basel
      10 Jun 2020—pharmaceutical-technology.com
      Life sciences incubator and accelerator BaseLaunch was founded three years ago to support “promising new biotech ventures move from really early academia to being able to do a Series A round,” director of strategy Neil Goldsmith explains. Backed by the three cantons of the Basel area and five large pharmaceutical companies – Basel-based Roche, Roivant and Novartis, as well as Johnson & Johnson and Pfizer – BaseLaunch has supported nine international ventures into Series A or equivalent rounds...

    People Also Viewed